These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 24491546
21. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death. Martín V, García-Santos G, Rodriguez-Blanco J, Casado-Zapico S, Sanchez-Sanchez A, Antolín I, Medina M, Rodriguez C. Cancer Lett; 2010 Jan 28; 287(2):216-23. PubMed ID: 19632770 [Abstract] [Full Text] [Related]
22. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway. Siegelin MD, Siegelin Y, Habel A, Rami A, Gaiser T. Neurobiol Dis; 2009 May 28; 34(2):259-66. PubMed ID: 19385057 [Abstract] [Full Text] [Related]
23. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY. Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429 [Abstract] [Full Text] [Related]
29. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 15; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
32. Short incubation with 2-methoxyestradiol kills malignant glioma cells independent of death receptor 5 upregulation. Braeuninger S, Chamaon K, Kropf S, Mawrin C, Wiedemann FR, Hartig R, Schoeler S, Dietzmann K, Kirches E. Clin Neuropathol; 2005 Dec 15; 24(4):175-83. PubMed ID: 16033134 [Abstract] [Full Text] [Related]
33. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639 [Abstract] [Full Text] [Related]
34. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T. Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136 [Abstract] [Full Text] [Related]
36. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA. Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726 [Abstract] [Full Text] [Related]
37. Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5. Chen CY, Yiin SJ, Hsu JL, Wang WC, Lin SC, Chern CL. J Agric Food Chem; 2012 Apr 04; 60(13):3533-9. PubMed ID: 22400995 [Abstract] [Full Text] [Related]
38. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway. Jane EP, Premkumar DR, Pollack IF. Mol Cancer Ther; 2011 Jan 04; 10(1):198-208. PubMed ID: 21220502 [Abstract] [Full Text] [Related]